What is the place of beta-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (mis)interpretation.

abstract：:The integrated response to severe exercise involves fourfold to fivefold increases in cardiac output, which are due primarily to increases in cardiac rate and to a lesser extent to augmentation of stroke volume. The increase in stroke volume is partly due to an increase in end-diastolic cardiac size (Frank-Starling me...

journal_title：Progress in cardiovascular diseases

authors： Vatner SF,Pagani M

更新日期：1976-09-01 00:00:00

abstract：:The revolution in cardiac care over the past two decades, characterized by emergent revascularization, drug eluting stents, anti-platelet medications, and advanced imaging has had little impact on overall ACS recurrence, or ACS prevention. The "Perfect Storm" refers to a confluence of events and processes, including a...

journal_title：Progress in cardiovascular diseases

authors： Burg MM,Edmondson D,Shimbo D,Shaffer J,Kronish IM,Whang W,Alcántara C,Schwartz JE,Muntner P,Davidson KW

更新日期：2013-05-01 00:00:00

abstract：:In our increasingly cost-conscious health system, patients, clinicians, hospitals, and payers all agree about the urgent need to rein in runaway healthcare costs. High pharmaceutical costs make drugs unaffordable to many patients who may benefit from them, including some insured patients who face prohibitive out-of-po...

journal_title：Progress in cardiovascular diseases

authors： Kazi DS,Virani SS

更新日期：2019-01-01 00:00:00

abstract：:A large number of drug trials for prevention of restenosis have been conducted with many showing little or conflicting benefit. Antiplatelets such as aspirin, ticlopidine and thromboxane A2 receptor inhibitors have not shown a clear benefit. Similarly, antithrombotics, either acting indirectly such as heparin, or as d...

journal_title：Progress in cardiovascular diseases

authors： Lefkovits J,Topol EJ

更新日期：1997-09-01 00:00:00

abstract：:Dispersion of ventricular repolarization is a now widely used term describing nonhomogeneous recovery of excitability or heterogeneity of ventricular repolarization. It is usually expressed as the difference or the range of various repolarization measurements obtained from a heart. Experimentally, an increased dispers...

journal_title：Progress in cardiovascular diseases

authors： Franz MR,Zabel M

更新日期：2000-03-01 00:00:00

abstract：:A hundred years from its description, Chagas cardiomyopathy remains a challenging disease. Although successful vector-control strategies have decreased the incidence of Chagas disease in several Latin American countries, both migration to urban areas and immigration have spread the disease worldwide; and now, blood tr...

journal_title：Progress in cardiovascular diseases

authors： Biolo A,Ribeiro AL,Clausell N

更新日期：2010-01-01 00:00:00

abstract：:Multimorbidity is the most common chronic health condition in adults and is associated with poor health outcomes. Optimal care for people with multimorbidity requires a person-centred approach that considers goals and preferences, improves quality of life and coordinates care across services. Because care is focused o...

journal_title：Progress in cardiovascular diseases

authors： Holland AE,Lee AL

更新日期：2019-01-01 00:00:00

abstract：:Studies performed in experimental animal models of hypertension as well as in human hypertension have unequivocally shown that reflex cardiovascular control undergoes profound changes with high blood pressure and participates throughout direct and indirect mechanisms at the development and progression of hypertension-...

journal_title：Progress in cardiovascular diseases

authors： Grassi G,Trevano FQ,Seravalle G,Scopelliti F,Mancia G

更新日期：2006-05-01 00:00:00

abstract：:The purpose of this article is to highlight approaches to increase movement, physical activity (PA), and cardiorespiratory fitness, and reduce sedentary behavior (SB) in the context of the workplace. A deliberate strategy that will enable the successful promotion of movement at the workplace includes a business plan a...

journal_title：Progress in cardiovascular diseases

authors： Pronk NP

更新日期：2020-10-24 00:00:00

abstract：:The epidemiology of cardiovascular diseases in sub-Saharan Africa is unique among world regions, with about half of cardiovascular diseases (CVDs) due to causes other than atherosclerosis. CVD epidemiology data are sparse and of uneven quality in sub-Saharan Africa. Using the available data, the Global Burden of Disea...

journal_title：Progress in cardiovascular diseases

authors： Moran A,Forouzanfar M,Sampson U,Chugh S,Feigin V,Mensah G

更新日期：2013-11-01 00:00:00

abstract：:Cardiac imaging plays an important role in coronary artery disease (CAD), congestive heart failure (HF) and valvular heart disease (VHD) in the elderly. Imaging defines the structure and function of the cardiac system, refining the understanding of patients' anatomy and physiology and informing a host of clinical care...

journal_title：Progress in cardiovascular diseases

authors： Mehta N,Chokshi NP,Kirkpatrick JN

更新日期：2014-09-01 00:00:00

abstract：:The QT Variability Index (QTVI) is a non-invasive measure of repolarization lability that has been applied to a wide variety of subjects with cardiovascular disease. It is a ratio of normalized QT variability to normalized heart rate variability, and therefore includes an assessment of autonomic nervous system tone. T...

journal_title：Progress in cardiovascular diseases

authors： Dobson CP,Kim A,Haigney M

更新日期：2013-09-01 00:00:00

abstract：:Telecardiology holds great promise for Africa, from tele-echocardiography and tele-ECG s, to home monitoring and text messaging for medication adherence monitoring. The burden of disease is great and there is an extreme shortage of health professionals. Telemedicine can provide access to scarce specialist care, improv...

journal_title：Progress in cardiovascular diseases

authors： Mars M

更新日期：2013-11-01 00:00:00

abstract：:To date there is no cure available for dementia, and the field calls for novel therapeutic targets. A rapidly growing body of literature suggests that regular endurance training and high cardiorespiratory fitness attenuate cognitive impairment and reduce dementia risk. Such benefits have recently been linked to system...

journal_title：Progress in cardiovascular diseases

authors： Tari AR,Norevik CS,Scrimgeour NR,Kobro-Flatmoen A,Storm-Mathisen J,Bergersen LH,Wrann CD,Selbæk G,Kivipelto M,Moreira JBN,Wisløff U

更新日期：2019-01-01 00:00:00

abstract：:The application of ultrasound to clinical evaluation of the symptomatic patient requires less precision and accuracy than when it is used as an instrument to study atherogenesis. The clinician's goal is to locate hemodynamically significant lesions; studies of atherogenesis require auxometry (measurement of the growth...

journal_title：Progress in cardiovascular diseases

authors： Blankenhorn DH,Rooney JA,Curry PJ

更新日期：1984-01-01 00:00:00

abstract：:Mitral regurgitation (MR) is the most prevalent cause of valvular heart disease (VHD) in western countries. In the Euro Heart Survey on VHD, MR was the second most common heart VHD requiring surgery. It is also the most common form of VHD in community and population-based studies from the United States. The categoriza...

journal_title：Progress in cardiovascular diseases

authors： Maréchaux S,Illman JE,Huynh J,Michelena HI,Nkomo VT,Tribouilloy C

更新日期：2017-01-01 00:00:00

abstract：:Patients with diabetes mellitus have an increased prevalence of hypertension and associated cardiovascular disease (CVD), including coronary and cerebrovascular disease. The risk of an individual of developing CVD is much greater when both diseases coexist and is further magnified by their frequent association with dy...

journal_title：Progress in cardiovascular diseases

authors： Guzmán CB,Sowers JR

更新日期：1999-05-01 00:00:00

abstract：:Pulmonary artery hypertension is a complex and multi-faceted disease process with numerous etiologies. Chronic thromboembolic pulmonary hypertension (CTEPH) is an underdiagnosed and highly treatable form of pulmonary hypertension. In this disease, certain patients with a history of pulmonary thromboembolic disease go ...

journal_title：Progress in cardiovascular diseases

authors： Haythe J

更新日期：2012-09-01 00:00:00

abstract：:Valvular heart disease (VHD) carries documented risks for active individuals. At the same time, many individuals with intermediate degrees of valve disease can safely exercise and even participate in competitive athletics. Unfortunately for clinicians caring for these patients, data are scarce. Understanding the patho...

journal_title：Progress in cardiovascular diseases

authors： Parker MW,Thompson PD

更新日期：2011-05-01 00:00:00

abstract：:Nearly 800,000 strokes occur in the United States each year, and stroke is the leading cause of preventable permanent disability. Timely recognition and treatment are imperative to reduce stroke-related morbidity and mortality. Given the evidence supporting intravenous thrombolysis and mechanical thrombectomy for isch...

journal_title：Progress in cardiovascular diseases

authors： Zweifler RM

更新日期：2017-01-01 00:00:00

abstract：:Echocardiography is a valuable technique for the diagnosis and serial follow-up of patients with impaired cardiac function. It is subject to certain limitations due to the assumptions inherent in deriving ventricular volume from a one-dimensional measurement and must be interpreted with caution in cases of suspected r...

journal_title：Progress in cardiovascular diseases

authors： Mason SJ,Fortuin NJ

更新日期：1978-09-01 00:00:00

abstract：:Obesity, particularly severe obesity is capable of producing hemodynamic alterations that predispose to changes in cardiac morphology and ventricular function. These include increased cardiac output, left ventricular hypertrophy and diastolic and systolic dysfunction of both ventricles. Facilitated by co-morbidities s...

journal_title：Progress in cardiovascular diseases

authors： Alpert MA,Omran J,Mehra A,Ardhanari S

更新日期：2014-01-01 00:00:00

abstract：:Stents or endoprostheses have evolved since their introduction. Initially used only in the vascular system, the use of stents has expanded to use in the biliary, urinary, and gastrointestinal tracts and in the tracheo-bronchial tree. Current use of stents includes treatment of both benign and malignant conditions, wit...

journal_title：Progress in cardiovascular diseases

authors： Vanderburgh L,Ho CS

更新日期：1996-09-01 00:00:00

abstract：:With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-positive patients in the "highly active antiretroviral therapy" (HAART) era, co-morbidities, particularly cardiovascular (CV) diseases (CVD) are emerging as an important concern. The pathophysiology of CVD in this population is comp...

journal_title：Progress in cardiovascular diseases

authors： Ballocca F,Gili S,D'Ascenzo F,Marra WG,Cannillo M,Calcagno A,Bonora S,Flammer A,Coppola J,Moretti C,Gaita F

更新日期：2016-03-01 00:00:00

abstract：:The role of antiarrhythmic agents in the post-MI patients has been investigated for several years. Recently, clinical trials have assessed the effects of amiodarone in the post-MI population. The Basel Antiarrhythmic Study of Infarct Survival (BASIS) trial showed a reduction in total mortality, sudden death, and life-...

journal_title：Progress in cardiovascular diseases

authors： Jafri SM,Borzak S,Goldberger J,Gheorghiade M

更新日期：1998-07-01 00:00:00

abstract：:Historically, risk stratification for survivors of acute myocardial infarction (AMI) has centered on 3 principles: assessment of left ventricular function, detection of residual myocardial ischemia, and estimation of the risk for sudden cardiac death. Although these factors still have important prognostic implications...

journal_title：Progress in cardiovascular diseases

authors： Michaels AD,Goldschlager N

更新日期：2000-01-01 00:00:00

abstract：:The recent advent of an entirely subcutaneous implantable defibrillator (ICD) has provided a relevant contribution to the debate concerning the use of ICD therapy in patients at high risk for death. Although conventional transvenous ICDs have proven very effective during the past 23 years, they still appear to be limi...

journal_title：Progress in cardiovascular diseases

authors： Lupo PP,Pelissero G,Ali H,Sanghera R,Cappato R

更新日期：2012-05-01 00:00:00

abstract：:Because not all laboratories use the monitoring and stimulation protocols used in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial, we reanalyzed the ESVEM patients' data using alternative, commonly used Holter monitor (HM) and programmed stimulation efficacy criteria to determine if d...

journal_title：Progress in cardiovascular diseases

authors： Reiffel JA,Reiter MJ,Freedman RA,Mann D,Huang SK,Hahn E,Hartz V,Mason J,ESVEM Investigators.

更新日期：1996-03-01 00:00:00

abstract：:Cardiovascular diseases (CVDs) are the leading cause of death and disability in India. Moreover, mortality following an acute myocardial infarction is high, which may be due to gaps in secondary prevention in general and a lack of cardiac rehabilitation (CR) services in particular. This review discusses the availabili...

journal_title：Progress in cardiovascular diseases

authors： Madan K,Babu AS,Contractor A,Sawhney JP,Prabhakaran D,Gupta R

更新日期：2014-03-01 00:00:00

abstract：:Bicuspid aortic valve (BAV) patients are at increased risk of valve dysfunction and ascending aorta aneurysm. Imaging techniques are essential to establish diagnosis, identify complications and indicate surgical treatment. Transthoracic echocardiography (TTE) is the imaging technique of choice to diagnose BAV, valve m...

journal_title：Progress in cardiovascular diseases

authors： Galian-Gay L,Rodríguez-Palomares J,Guala A,Michelena HI,Evangelista A

更新日期：2020-01-01 00:00:00